Mirae Asset Global Etfs Holdings Ltd. Maxcyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 59,929 shares of MXCT stock, worth $230,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,929
Previous 57,345
4.51%
Holding current value
$230,726
Previous $223,000
11.66%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$36 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$31.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$20.9 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$19.4 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$17 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $392M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...